Background: the objective of the study was to estimate and compare the incidence rates of ischaemic and haemorrhagic stroke and seizure among cohorts with and without Alzheimer's disease (AD) dementia. Methods: we conducted a retrospective cohort study using electronic medical records (EMRs) from primary care practices that participated in The Health Improvement Network (THIN) in the United Kingdom from 1 January 1990 to 31 July 2009. For each AD-dementia patient, we selected one general population control patient without AD-dementia matched to one ADdementia patient on year of birth, sex and physician practice. Findings: the AD-dementia cohorts were 68% female and averaged 80 years of age at the start of follow-up. Populations for analysis included 19,902 AD-dementia and matched non-AD-dementia patients with no history of stroke at baseline in which 790 incident cases of stroke occurred, and similarly, 22,084 AD-dementia and matched patients with no history of seizure at baseline in which 286 cases of seizure occurred. After adjusting for risk factors for each outcome, hazard ratios comparing AD-dementia with non-AD-dementia patients indicated higher rates among AD-dementia patients for stroke (HR = 1.29, 95% CI 1.11, 1.50) and seizure (HR = 5.31, 95% CI 3.97, 7.10). For stroke and seizure, the incidence rate ratios comparing AD-dementia patients with non-AD-dementia controls were greatest for the younger age groups. AD-dementia was observed to be a risk factor for both haemorrhagic stroke and seizures. Increasing age was associated with a decrease in relative risk and an increase in absolute risk.
Introduction
Vascular pathology has been consistently identified as a risk factor for dementia and specifically for Alzheimer's disease (AD) dementia [1] [2] [3] [4] .
The objectives of this study are to characterise the risk of seizures, haemorrhagic and ischaemic events among patients with AD-dementia and, whether the risks, if any, are associated with age or gender.
Methods
The study population was selected from The Health Improvement Network (THIN) database from the period (1 January 1990 to 31 July 2009). THIN is an electronic medical record (EMR) database in the United Kingdom that contains de-identified and anonymised, computerised medical information entered by general practitioners (GPs). The THIN database contains information on 7.7 million patients from >400 GPs in the United Kingdom. Complete cohort identification is included in supplementary text along with the findings of the validation study for the outcomes, stroke and seizure, see Supplementary data, Appendix S1 and Tables S1-S3, available in Age and Ageing online.
An application for this study was submitted to the National Health Service and received a favourable ethical opinion from the Research Ethics Committee on 11 March 2009.
Statistical analysis
Unadjusted incidence rate ratios and 95% CIs for the outcomes of interest were calculated by comparing the rates observed in AD-dementia patients with the rates observed in the non-AD-dementia population. Kaplan-Meier survival curves were generated to describe the cumulative probability of the occurrence of each endpoint over time for both the AD-dementia population and the non-AD-dementia population. Cox proportional hazards regression models were constructed to compute hazard ratios (HRs) for each endpoint among AD-dementia patients and non-AD-dementia patients adjusting for baseline risk factors.
Statistical analyses were conducted in SAS (version 9.2, SAS Institute, Cary, NC, USA) and Stata (version 11.0, Stata Corp., College Station, TX, USA).
Results

Stroke incidence
We identified 19,902 patients, including 9,951 AD-dementia and 9,951 matched non-AD-dementia patients, see Supplementary data, Table S4 , available in Age and Ageing online. As a sensitivity analysis, we identified any non-AD-dementia patients who were later diagnosed with AD-dementia or received an AD-defining drug therapy during follow-up. Less than 2% of the non-AD-dementia patient cohort was eventually censored because of an AD-dementia diagnosis or AD-defining drug therapy during follow-up. Incidence rates of stroke were 15.9/1,000 person-years among AD-dementia patients and 12.0/1,000 person-years among non-AD-dementia patients (RR = 1.33, 95% CI = 1.15, 1.53). Incidence rates increased with age and were similar for men and women. The difference in incidence of stroke between AD-dementia and non-AD-dementia patients was greatest for patients aged 50-69 years (RR = 3.03, 95% CI 1.70, 5.57) and declined with increasing age, see Supplementary data, Table S5 , available in Age and Ageing online.
After adjustment for baseline risk factors, the association between stroke incidence rates in AD-dementia patients and non-AD-dementia patients was similar (HR = 1.29, 95% CI 1.11, 1.50) ( Table 1 ). Of the baseline risk factors we studied, only asthma was associated with a decreased risk of stroke event (HR = 0.67, 95% CI 0.48, 0.93). Both depression (HR = 1.23, 95% CI 1.02, 1.49) and kidney failure (HR = 1.53, 95% CI 1.10, 2.13) were associated with an increased risk of stroke event.
For cases identified as ischaemic stroke, incidence rates were similar for AD-dementia and non-AD-dementia patients (RR = 1.06, 95% CI 0.87, 1.28). For patients aged 50-65 years, the risk of ischaemic stroke may be considered increased (RR = 1.92, 95% CI 0.97, 3.87). After adjusting for baseline risk factors, there was little overall association (HR = 1.02, 95% CI 0.84, 1.25). Males had an increased risk of ischaemic stroke when compared with females (HR = 1.31, 95% CI 1.08, 1.60), and patients aged 70 and greater had an increased risk of ischaemic stroke compared with those aged 50-69. For haemorrhagic stroke, incidence was greater among AD-dementia patients (RR = 1.63, 95% CI 1.17, 2.27), particularly for patients aged 50-65 years (RR = 6.99, 95% CI 1.45, 66. 
Seizure incidence
We identified 22,084 patients for inclusion in the seizure analysis, 11,042 patients in both the AD-dementia cohort and the matched non-AD-dementia cohort. In both cohorts, 67% were female, and the mean age was about 80 years at start of follow-up. Incidence rates of seizure were 8.8 per 1,000 person-years among AD-dementia patients and 1.7 per 1,000 person-years among non-AD-dementia patients (RR = 5.28, 95% CI 4.00, 7.05), among 286 seizure events, see Supplementary data, Table S6 , available in Age and Ageing online. The greatest difference in incidence of seizure between AD-dementia and non-AD-dementia patients was observed among patients aged 50-60 (RR = 28.89, 95% CI 10.81, 108.88). The difference in incidence decreased as age increased, and the smallest difference was observed among those aged 85+ (RR = 2.70, 95% CI 1.47, 5.11). After adjusting for baseline predictors of seizures, the increased risk of seizure among AD-dementia patients persisted (HR = 5.31, 95% CI 3.97, 7.10) ( Table 2) . Compared with those aged 50-69 years, patients aged 70 years or more all had lower risk of seizures. Only a history of stroke (HR = 2.03, 95% CI 1.45. 2.83) and antipsychotics prescribed within 6 months before index date (HR = 1.66, 95% CI 1.19, 2.32) were associated with an increased risk of seizure event.
Discussion
The observations from this study indicate an increased risk of haemorrhagic stroke but not ischaemic stroke among persons with AD compared with those without AD. A noticeable inverse relationship with age was observed with substantially increased relative risk at the relatively younger ages, those aged <80 years. Conversely, the absolute risk, that is the underlying rate difference, increased with increasing age. The risk of haemorrhagic stroke remained elevated irrespective of gender and after controlling for common factors.
Our observations of AD and the risk of cerebrovascular events were similar to those of Tolppanen [5] with respect to haemorrhagic stroke and the inverse relationship between age and relative risk, and no observed increase among those aged 80 years or older. The lack of an observed association with ischaemic events was consistent with their findings. Our observations were not entirely consistent with Chi [6] , who observed increased risk associated with AD for both ischaemic and haemorrhagic stroke.
As with stroke, AD-dementia is a risk factor for seizures with increasing relative risk associated with younger age, a finding similar to Amatniek [7] with a re-evaluation and analysis published in 2009 [8] . Our findings are consistent with the two publications with respect to both, the increased relative risk and the inverse relationship with age. The relative risk for seizure is highest at the youngest ages studied with the absolute risk increasing with increasing age.
A key strength of this study was the use of EMRs from community-based, not-hospital-based, medical practices. The large number of subjects with a diagnosis of AD-dementia and a corresponding number without AD in the analyses provide numeric precision around the estimates. A retrospective cohort design was used with an inception cohort of patients with incident AD whose first recorded AD diagnosis was preceded by a baseline period of at least 6 months. The validation study demonstrated reasonable accuracy, 90% for the stroke endpoints and 80% for the seizure endpoints (Supplementary data, Table S2 , available in Age and Ageing online).
Some limitations of the study include the small number of stroke subtypes, such as haemorrhagic and subdural events, which preclude detailed evaluation of stroke. The use of EMRs identified a substantial number of subjects who did not have confirmatory information on smoking status and body mass index. As both the diagnosis of AD-dementia and stroke events were based on clinical diagnosis and coding in the EMRs, outcome misclassification was possible. As this misclassification was presumed to non-differential with respect to AD-dementia, the likely impact would be an attenuation of the observed association towards the null value.
Clinical confirmation of a seizure is challenging in clinical practice; thus, misclassification is likely, which may result in an attenuated relative risk [8] .
This study contributes to the growing body of evidence that AD-dementia is a risk factor for stroke, which may reflect a common underlying pathology, such as amyloid deposition and inflammation [1] [2] [3] [4] [9] [10] [11] [12] . The attenuation of the associated stroke risk with increasing age is a critical factor when evaluating patients, exploring the pathology and considering patients for enrollment in clinical trials.
Consistent with the observations of other researchers, AD-dementia was observed to be a risk factor for both haemorrhagic stroke and seizures. A decreased relative risk and an increased absolute risk were both associated with increasing age.
Key points
• Patients with Alzheimer's disease dementia are at greater risk of haemorrhagic strokes than the general population.
• Patients with Alzheimer's disease dementia are at greater risk of seizures than the general population.
• The increased risk for haemorrhagic stroke and seizures is at younger ages.
Supplementary data
Supplementary data mentioned in the text are available to subscribers in Age and Ageing online.
